Astrana Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Astrana Health Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ASTH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001083446
Board of directors
-
David Schmidt · DirectorSince 2023
-
John Chiang · DirectorSince 2023
-
Kenneth T. Sim · Director · Executive ChairmanSince 2023
-
Linda Marsh · DirectorSince 2023
-
Matthew Mazdyasni · DirectorSince 2023
-
Mitchell W. Kitayama · DirectorSince 2023
-
Thomas S. Lam · Director · President and Co-CEOSince 2023
-
Weili Dai · DirectorSince 2023
Chief executives
Thomas S. Lam
· President and Co-CEO
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via John Chiang
- via Linda Marsh
- via John Chiang
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Sobotka Glenn Officer (Chief Accounting Officer) | Shares withheld for tax | −662 | $24.27 | $16,067 |
| Mar 5, 2026 | Thomas S. Lam Director | Shares withheld for tax | −9,266 | $25.07 | $232,299 |
| Mar 5, 2026 | Kumar Dinesh M. Officer (Chief Medical Officer) | Shares withheld for tax | −1,697 | $25.07 | $42,544 |
| Mar 5, 2026 | Basho Chandan Officer (COO and CFO) | Shares withheld for tax | −1,240 | $25.07 | $31,087 |
| Dec 8, 2025 | Thomas S. Lam Director | Option exercise | +29,502 | $17.78 | $524,546 |
| Dec 8, 2025 | Thomas S. Lam Director | Shares withheld for tax | −25,866 | $22.00 | $569,052 |
| Nov 10, 2025 | Kenneth T. Sim Director, Officer (Executive Chairman) | Option exercise | +29,502 | $17.78 | $524,546 |
| Nov 10, 2025 | Matthew Mazdyasni Director | Option exercise | +20,000 | $18.20 | $364,000 |
| Nov 7, 2025 | Mitchell W. Kitayama Director | Option exercise | +12,000 | $18.20 | $218,400 |
| Nov 3, 2025 | Linda Marsh Director | Option exercise | +20,000 | $18.20 | $364,000 |
| Nov 3, 2025 | Linda Marsh Director | Shares withheld for tax | −11,033 | $32.99 | $363,979 |
| Oct 2, 2025 | Basho Chandan Officer (COO and CFO) | Shares withheld for tax | −1,979 | $27.77 | $54,957 |
| Sep 15, 2025 | Mitchell W. Kitayama Director | Option exercise | +8,000 | $18.20 | $145,600 |
| Sep 15, 2025 | Mitchell W. Kitayama Director | Sold back to the company | −8,000 | $30.23 | $241,840 |
| Sep 15, 2025 | Mitchell W. Kitayama Director | Sold back to the company | −5,214 | $30.23 | $157,619 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.